Our Portfolio

STELLA PHARMA CORPORATION

Outline R&D, manufacturing and sales of medical products and medical devices
Website

http://www.stella-pharma.co.jp/

Industry Health/medicine
Commercialization stage Venture company

Provided Support

  • Targeting world-first regulatory approval and commercialization of BNCT, a new type of cancer treatments
  • Driving innovative medical technology development by open innovation across manufacturing industries and domestic academia
Authorized Investment 3.5 billion yen (maximum)
Announcement Date Mar 24, 2016
Investment Structure

Related Press Releases

Mar 24, 2016
INCJ and Sumitomo Heavy Industries, Ltd. to invest in STELLA PHARMA CORPORATION, developer of boron-based drugs used for Boron Neutron Capture Therapy (BNCT)
HOME
About Us
Our Business
Newsroom
Our Investments